Clustered de novo start-loss variants in GLUL result in a developmental and epileptic encephalopathy via stabilization of glutamine synthetase.
GLUL
degron motif
epileptic encephalopathies
glutamine metabolism
glutamine synthetase
Journal
American journal of human genetics
ISSN: 1537-6605
Titre abrégé: Am J Hum Genet
Pays: United States
ID NLM: 0370475
Informations de publication
Date de publication:
04 Apr 2024
04 Apr 2024
Historique:
received:
19
12
2023
revised:
05
03
2024
accepted:
06
03
2024
pmc-release:
04
10
2024
medline:
8
4
2024
pubmed:
6
4
2024
entrez:
5
4
2024
Statut:
ppublish
Résumé
Glutamine synthetase (GS), encoded by GLUL, catalyzes the conversion of glutamate to glutamine. GS is pivotal for the generation of the neurotransmitters glutamate and gamma-aminobutyric acid and is the primary mechanism of ammonia detoxification in the brain. GS levels are regulated post-translationally by an N-terminal degron that enables the ubiquitin-mediated degradation of GS in a glutamine-induced manner. GS deficiency in humans is known to lead to neurological defects and death in infancy, yet how dysregulation of the degron-mediated control of GS levels might affect neurodevelopment is unknown. We ascertained nine individuals with severe developmental delay, seizures, and white matter abnormalities but normal plasma and cerebrospinal fluid biochemistry with de novo variants in GLUL. Seven out of nine were start-loss variants and two out of nine disrupted 5' UTR splicing resulting in splice exclusion of the initiation codon. Using transfection-based expression systems and mass spectrometry, these variants were shown to lead to translation initiation of GS from methionine 18, downstream of the N-terminal degron motif, resulting in a protein that is stable and enzymatically competent but insensitive to negative feedback by glutamine. Analysis of human single-cell transcriptomes demonstrated that GLUL is widely expressed in neuro- and glial-progenitor cells and mature astrocytes but not in post-mitotic neurons. One individual with a start-loss GLUL variant demonstrated periventricular nodular heterotopia, a neuronal migration disorder, yet overexpression of stabilized GS in mice using in utero electroporation demonstrated no migratory deficits. These findings underline the importance of tight regulation of glutamine metabolism during neurodevelopment in humans.
Identifiants
pubmed: 38579670
pii: S0002-9297(24)00078-8
doi: 10.1016/j.ajhg.2024.03.005
pmc: PMC11023914
pii:
doi:
Substances chimiques
GLUL protein, human
EC 6.3.1.2
Glul protein, mouse
EC 6.3.1.2
Glutamate-Ammonia Ligase
EC 6.3.1.2
Glutamates
0
Glutamine
0RH81L854J
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
729-741Informations de copyright
Copyright © 2024 American Society of Human Genetics. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests The authors declare no competing interests.
Références
Cell. 2022 Nov 10;185(23):4428-4447.e28
pubmed: 36318921
J Neurochem. 2006 Aug;98(3):641-53
pubmed: 16787421
Med. 2022 Nov 11;3(11):792-811.e12
pubmed: 36108629
Mol Cell. 2016 Mar 17;61(6):809-20
pubmed: 26990986
Nature. 2018 Sep;561(7721):63-69
pubmed: 30158707
Nat Biotechnol. 2018 Jun;36(5):411-420
pubmed: 29608179
Int J Mol Sci. 2018 Apr 12;19(4):
pubmed: 29649168
Am J Hum Genet. 2021 May 6;108(5):857-873
pubmed: 33961779
Clin Genet. 2018 Dec;94(6):538-547
pubmed: 30280376
Neuron. 2006 Mar 16;49(6):823-32
pubmed: 16543131
Neuron. 2020 Mar 4;105(5):867-881.e9
pubmed: 31883789
Neurotherapeutics. 2010 Oct;7(4):452-70
pubmed: 20880508
Expert Opin Ther Targets. 2017 May;21(5):461-469
pubmed: 28292200
Am J Hum Genet. 2016 Oct 6;99(4):802-816
pubmed: 27616483
Neuron. 2014 Feb 19;81(4):814-29
pubmed: 24559674
N Engl J Med. 2005 Nov 3;353(18):1926-33
pubmed: 16267323
Neuron. 2021 Feb 3;109(3):408-419
pubmed: 33306962
Rev Endocr Metab Disord. 2010 Sep;11(3):171-8
pubmed: 20936362
Metab Brain Dis. 2014 Dec;29(4):983-9
pubmed: 24136581
Genet Med. 2019 Jan;21(1):102-106
pubmed: 29884839
Hum Mol Genet. 2019 Jan 1;28(1):96-104
pubmed: 30239721
NMR Biomed. 2013 Dec;26(12):1630-46
pubmed: 24123328
Cell. 2019 Jan 24;176(3):535-548.e24
pubmed: 30661751
Hum Mutat. 2015 Oct;36(10):928-30
pubmed: 26220891
Cell. 2019 Jun 13;177(7):1888-1902.e21
pubmed: 31178118
Biology (Basel). 2016 Oct 19;5(4):
pubmed: 27775558
Exp Mol Med. 2020 Sep;52(9):1496-1516
pubmed: 32943735
Science. 2015 Mar 27;347(6229):1465-70
pubmed: 25721503
Nutrients. 2019 Jul 19;11(7):
pubmed: 31330962